Super V3 Investment Limited Partnership Jafco is 10% at Eleven Biotherapeutics, Inc. (EBIO). They have made 33 open-market trades across 2 companies since 2014, most recently 2015-10-16.
CIK 0001590442
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $4.8M since 2014, against 31 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 39% | 52% |
| Avg Move | -18.7% | -0.4% | -2.3% |
| Scored | 31 | 31 | 31 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TCON | SELL | 2015-10-16 | 2015-10-19 | $9.90 | $15K | -16.0% | +1.0% | -19.6% |
| TCON | SELL | 2015-10-15 | 2015-10-15 | $10.16 | $54K | -16.0% | +1.0% | -16.0% |
| TCON | SELL | 2015-10-09 | 2015-10-13 | $10.01 | $32K | -16.0% | +1.0% | -9.8% |
| TCON | SELL | 2015-10-07 | 2015-10-08 | $10.10 | $221K | -16.0% | +1.0% | -7.3% |
| TCON | SELL | 2015-10-02 | 2015-10-06 | $10.08 | $152K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-09-25 | 2015-09-29 | $12.13 | $92K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-09-23 | 2015-09-24 | $12.99 | $290K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-09-21 | 2015-09-22 | $14.02 | $553K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-09-15 | 2015-09-17 | $11.78 | $499K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-09-10 | 2015-09-14 | $11.78 | $707K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-09-04 | 2015-09-09 | $10.59 | $257K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-09-02 | 2015-09-03 | $10.51 | $161K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-08-31 | 2015-09-01 | $10.42 | $146K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-08-24 | 2015-08-25 | $11.00 | $33K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-08-19 | 2015-08-20 | $11.36 | $121K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-08-14 | 2015-08-18 | $11.71 | $131K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-08-12 | 2015-08-14 | $11.60 | $109K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-08-11 | 2015-08-12 | $11.40 | $66K | -16.0% | +1.0% | +1.0% |
| TCON | SELL | 2015-08-07 | 2015-08-11 | $11.59 | $96K | -16.0% | +1.0% | +1.0% |
| EBIO | SELL | 2015-05-08 | 2015-05-11 | $13.23 | $442K | -22.9% | -2.7% | -2.7% |
| TCON | BUY | 2015-02-04 | 2015-02-17 | $10.00 | $2.6M | -16.0% | +1.0% | +1.0% |
| EBIO | SELL | 2015-02-02 | 2015-02-03 | $11.62 | $208K | -22.9% | -2.7% | -2.7% |
| EBIO | SELL | 2015-01-28 | 2015-01-30 | $11.62 | $1.4M | -22.9% | -2.7% | -2.7% |
| EBIO | SELL | 2015-01-27 | 2015-02-09 | $11.66 | $26K | -22.9% | -2.7% | -2.7% |
| EBIO | SELL | 2015-01-23 | 2015-01-26 | $11.85 | $75K | -22.9% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.